Publication | Open Access
A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma
92
Citations
17
References
2016
Year
Our findings support the use CP class A as an inclusion criterion, and ALBI as a stratification factor in trials of systemic therapy.
| Year | Citations | |
|---|---|---|
2015 | 27.2K | |
1973 | 7.9K | |
2012 | 5.2K | |
2000 | 2.9K | |
2014 | 2.6K | |
2007 | 1.7K | |
2005 | 633 | |
1966 | 292 | |
2001 | 278 | |
2015 | 243 |
Page 1
Page 1